13F-HR filed by EcoR1 Capital, LLC
EcoR1 Capital, LLC filed this 13F-HR for the quarter ended 2019-12-31, filed 2020-02-14, with 44 holding rows worth $1,091,527,000.
- Accession
- 0001567619-20-003991
- Filer
- CIK 1587114
- Filed
- 2020-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2019
A holdings report, 44 entries on the cover page, a total value of $1,091,527,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,091,527,000 with VALUE read as thousands by filing date, 13F file number 028-16764. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PROTHENA CORP PLC SHS | G72800108 | Stock | 9,426,640 | $149,224,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 3,627,597 | $79,916,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 1,979,783 | $68,085,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 1,492,221 | $64,001,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 4,241,953 | $58,327,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 4,371,408 | $58,183,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 1,339,069 | $55,022,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 2,388,268 | $48,864,000 | thousands by filing date | |
| NEOLEUKIN THERAPEUTICS INC | 64049K104 | COM | 3,915,880 | $48,244,000 | thousands by filing date | |
| MORPHIC HLDG INC | 61775R105 | COM | 2,154,845 | $36,977,000 | thousands by filing date | |
| PREVAIL THERAPEUTICS INC | 74140Y101 | COM | 2,248,306 | $35,591,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 202,117 | $32,444,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 1,966,100 | $31,949,000 | thousands by filing date | |
| INNATE PHARMA S A | 45781K204 | SPONSORED ADS | 4,545,454 | $29,273,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 676,500 | $29,015,000 | thousands by filing date | call |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 312,500 | $26,422,000 | thousands by filing date | call |
| MERUS N V | N5749R100 | COM | 1,718,200 | $24,192,000 | thousands by filing date | |
| ATRECA INC | 04965G109 | COM | 1,481,411 | $22,917,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 500,000 | $21,390,000 | thousands by filing date | |
| CHIASMA INC | 16706W102 | COM | 3,043,827 | $15,097,000 | thousands by filing date | |
| HARPOON THERAPEUTICS INC | 41358P106 | COM | 908,547 | $13,437,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 173,364 | $12,515,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 261,554 | $11,171,000 | thousands by filing date | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 4,597,701 | $10,943,000 | thousands by filing date | |
| EXICURE INC | 30205M101 | COM | 3,544,186 | $10,136,000 | thousands by filing date | |
| PIERIS PHARMACEUTICALS INC | 720795103 | COM | 2,535,212 | $9,177,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 451,354 | $8,833,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 65,000 | $8,376,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 729,905 | $7,372,000 | thousands by filing date | |
| EVOLUS INC | 30052C107 | COM | 600,000 | $7,302,000 | thousands by filing date | |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 449,338 | $6,695,000 | thousands by filing date | |
| SAVARA INC | 805111101 | COM | 1,432,664 | $6,418,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 213,647 | $5,914,000 | thousands by filing date | |
| RUBIUS THERAPEUTICS INC | 78116T103 | COM | 525,877 | $4,996,000 | thousands by filing date | |
| CYCLERION THERAPEUTICS INC | 23255M105 | COM | 1,811,000 | $4,926,000 | thousands by filing date | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 415,400 | $4,445,000 | thousands by filing date | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 737,612 | $4,013,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 2,087,312 | $3,945,000 | thousands by filing date | |
| IGM BIOSCIENCES INC | 449585108 | COM | 100,000 | $3,816,000 | thousands by filing date | |
| TCR2 THERAPEUTICS INC | 87808K106 | COM | 239,500 | $3,420,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 410,000 | $3,407,000 | thousands by filing date | |
| SURFACE ONCOLOGY INC | 86877M209 | COM | 1,301,713 | $2,447,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 131,001 | $2,279,000 | thousands by filing date | |
| UROVANT SCIENCES | G9381B108 | COMMON STOCK | 26,468 | $411,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001567619-20-003991 | this filing | 2020-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001567619-20-004215 | base | 2020-02-18 | acceptance time not in the bulk data set |